GlaxoSmithKline PLC (GSK)
Symbol Info
Listed Symbol GSK
Name GlaxoSmithKline PLC
Share Info
Annual Info
Latest Fiscal Dividend Per Share $2.05
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $39,256,676,879
Latest Fiscal EPS $1.86
Price Info
21 Day Moving Average $41.7424
21 Day EMA $41.821380
50 Day Moving Average $41.2501
50 Day EMA $41.382780
200 Day EMA $39.979640
200 Day Moving Average 39.757440
52 Week High $43.22
52 Week Low $36.41
52 Week Change $15.282499
Alpha -0.000617
Beta 0.6936
Standard Deviation 0.047267
R2 0.254219
Periods 60
Share Information
10 Day Average Volume 2,273,770
20 Day Average Volume 2,261,454
30 Day Average Volume 2,259,003
50 Day Average Volume 2,250,103
Outstanding Shares 2,494,362,150
Float Shares 2,494,362,150
Percent Float 100.00%
Short Interest 6,560,875
Short Percent Float 0.30%
Short Interest Ratio 2.89
Short Date 2019-09-13
Holders
Institutions 1,106
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 14,409,265
Institute Holdings Percent 12.700000
Institute Sold Previous 3 Months 15,061,131
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $0.1899986
7 Day Percent Change 0.45%
21 Day Price Change $0.5499992
21 Day Percent Change 1.32%
30 Day Price Change $1.3600006
30 Day Percent Change 3.33%
Month To Date Price Change $-0.5
Month To Date Percent -1.17%
90 Day Price Change $1.720654
90 Day Percent Change 4.25%
Quarter To Date $-0.5
Quarter To Date Percent -1.17%
180 Day Price Change $2.194416
180 Day Percent Change 5.49%
200 Day Price Change $1.930714
200 Day Percent Change 4.80%
Year To Date $5.403732
Year To Date Percent 14.69%
Profile
Description In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.
Details
Issue Type CS
Market Cap $105,212,195,487
Sec Type DR
Auditor
Total Shares Outstanding 2,494,362,150
CEO Emma N Walmsley
Employees 113,245
Last Audit
Classification
CIK 0001131399
Industry Drug Manufacturers
Sector Healthcare
NAICS
Info
Address 980 Great West Road
Brentford, Middlesex TW8 9GS
Website http://www.gsk.com
Facisimile +44 2080477807
Telephone +44 2080475000
Email company.secretary@gsk.com
Key Ratios
Profitability
EBIT Margin 20.50
EBITDA Margin 30.4
Pre-Tax Profit Margin 18.2
Profit Margin Cont 14.14
Gross Margin 65.60
Profit Margin TOT 14.14
Income Statements
Revenue $29,416,816,289
Revenue Per Share $948.8198
Revenue 3 Years $-0.27
Revenue 5 Years $4.38
Valuation Measures
PE Ratio 18.20
Enterprise Value $142,939,146,166
Price To Sales 0.044455
Price To Free Cash -39.6
PE High Last 5 Years 97.0
Price To Book 23.1
Price To Cash Flow 10.1
PE Low Last 5 Years 7.3
Price To Tangible Book -3.4
Financial Strength
Total Debt To Equity 9.3
Int Coverage 7.5
Current Ratio 0.7
Leverage Ratio 16.7
Quick Ratio 0.2
Long Term Debt To Capital 0.87
Assets
Receivables Turnover -
Invoice Turnover 1.80
Assets Turnover 0.40
Management Effectiveness
Return Assets 7.16
Return On Equity 118.98
Return On Capital 14.89
Dividends
Dividend 3 Years $-1.28
Dividend 5 Years $-4.64
Ex Dividend Date 2019-08-08 00:00:00.0
Dividend Rate $1.86
Dividend Yield 4.42%
Payment Type Cash


Your Recent History
NYSE
GSK
GlaxoSmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.